Ziftomenib
(zif-toe-MEN-ib)
This page contains brief information about ziftomenib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Komzifti
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Ziftomenib is approved to treat adults with:
- acute myeloid leukemia (certain types) that came back or did not respond to treatment
More About Ziftomenib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Ziftomenib - A lay language summary of important information about this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Zifromenib - Check for trials from NCI's list of cancer clinical trials now accepting patients.